V15I (p.Val15Ile) variant of GAA (Lysosomal alpha-glucosidase)
V15I (p.Val15Ile) in GAA (Lysosomal alpha-glucosidase) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of not provided; Glycogen storage disease, type II. The available variant effect predictions contribute to a CATVariant prioritization score of 0.16 / 1. The record also includes population frequency data, published literature, and structural context.
V15I (p.Val15Ile) variant details
- p.Val15Ile
- rs772157487
- ClinGen CA8814768
- ClinVar RCV000706241
- ClinVar RCV005056456
- Uncertain significance
- not provided; Glycogen storage disease, type II
- Missense
- Variant Prioritization Score for Impact Estimate 0.165
- REVEL 0.17
- MetaLR 0.39
- MetaSVM -0.63
- CADD 0.00
- PolyPhen-2 0.00
- SIFT 0.33
- ClinVar: Uncertain significance (not provided; Glycogen storage disease, type II)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Most common in the REMAINING population (allele frequency 0.00048)
- Structural context available
- Cited in: Pompe Disease. (PMID 20301438)
- Cited in: 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and… (PMID 25173338)